Evidence map›Paper›PMID 25598323›Full record

ArticleInternational journal of cancer2015

General and abdominal obesity and risk of esophageal and gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition.

Annika Steffen, José-Maria Huerta, Elisabete Weiderpass, H B As Bueno-de-Mesquita, Anne M May, Peter D Siersema, Rudolf Kaaks, Jasmine Neamat-Allah, Valeria Pala, Salvatore Panico and 29 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in International journal of cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 7 pooled it
9.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 7 syntheses or guidelines pooled it, 105 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Cancer Risk in Barrett's Esophagus: A Clinical Review.International journal of molecular sciences · 2023
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

39 authors at 20 institutions in 13 countries.

Annika SteffenDepartment of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
José-Maria HuertaDepartment of Epidemiology, Murcia Regional Health Council, Murcia, Spain.
Elisabete WeiderpassDepartment of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.
H B As Bueno-de-MesquitaNational Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Anne M MayJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands.
Peter D SiersemaDepartment of Gastroenterology and Hepatology, University Medical Centre, Utrecht, The Netherlands.
Rudolf KaaksDivision of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.
Jasmine Neamat-AllahDivision of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.
Valeria PalaEpidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Salvatore PanicoDipartmento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy.
Calogero SaievaMolecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute-ISPO, Florence, Italy.
Rosario TuminoCancer Registry and Histopathology Unit, "Civic-M.P. Arezzo" Hospital, ASP Ragusa, Ragusa, Italy.
Alessio NaccaratiHuman Genetics Foundation (HuGeF), Torino, Italy.
Miren DorronsoroPublic Health Direction and Biodonostia-Ciberesp, Basque Regional Health Department, Vitoria, Spain.
Emilio Sánchez-CantalejoCIBER Epidemiología y Salud Pública (CIBERESP), Spain.
Eva ArdanazCIBER Epidemiología y Salud Pública (CIBERESP), Spain.
J Ramón QuirósPublic Health Directorate, Asturias, Spain.
Bodil OhlssonDivision of Internal Medicine, Department of Clinical Sciences, Skåne University Hospital, Malmö, Lund University, Lund, Sweden.
Mattias JohanssonDepartment for Biobank Research, Umeå University, Umeå, Sweden.
Bengt WallnerDepartment of Surgical and Perioperative Sciences, Umeå University, Umeå, Sweden.
Kim OvervadSection for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark.
Jytte HalkjaerDanish Cancer Society Research Center, Copenhagen, Denmark.
Anne TjønnelandDanish Cancer Society Research Center, Copenhagen, Denmark.
Guy FagherazziInserm, Centre for research in Epidemiology and Population Health (CESP), Nutrition, Hormones and Women's Health team, Villejuif, France.
Antoine RacineInserm, Centre for research in Epidemiology and Population Health (CESP), Nutrition, Hormones and Women's Health team, Villejuif, France.
Françoise Clavel-ChapelonInserm, Centre for research in Epidemiology and Population Health (CESP), Nutrition, Hormones and Women's Health team, Villejuif, France.
Tim J KeyCancer Epidemiology Unit, University of Oxford, Oxford, United Kingdom.
Kay-Tee KhawUniversity of Cambridge, Cambridge, United Kingdom.
Nick WarehamMRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
Pagona LagiouDepartment of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, Athens, Greece.
Christina BamiaDepartment of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, Athens, Greece.
Antonia TrichopoulouHellenic Health Foundation, Athens, Greece.
Pietro FerrariInternational Agency for Research on Cancer (IARC-WHO), Lyon, France.
Heinz FreislingInternational Agency for Research on Cancer (IARC-WHO), Lyon, France.
Yunxia LuDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
Elio RiboliDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
Amanda J CrossDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
Carlos A GonzalezUnit of Nutrition, Environment and Cancer, Programme of Epidemiological Research, Catalan Institute of Oncology, Barcelona (ICO-IDIBELL), Spain.
Heiner BoeingDepartment of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
Centre international de recherche sur le cancer · FRImperial College London · GBInserm · FRUniversity Medical Center Utrecht · NLCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESDanish Cancer Society · DKGerman Cancer Research Center · DEGerman Institute of Human Nutrition · DEUniversity of Cambridge · GBAarhus University · DKAcademy of Athens · GRAzienda Usl 8 Arezzo · ITBasque Government · ESFederico II University Hospital · ITFondazione IRCCS Istituto Nazionale dei Tumori · ITGobierno del Principado de Asturias · ESHarvard University · USInstitut d'Investigació Biomédica de Bellvitge · ESInstituto de Investigación Biosanitaria de Granada · ESItalian institute for Genomic Medicine · IT

Funding

Cancer Research UK 14136Cancer Research UK 16491Medical Research Council G0401527Medical Research Council G1000143Medical Research Council MC_U106179471Medical Research Council MC_UU_12015/1World Health Organization 001
6 · The paper itself

Abstract

General obesity, as reflected by BMI, is an established risk factor for esophageal adenocarcinoma (EAC), a suspected risk factor for gastric cardia adenocarcinoma (GCC) and appears unrelated to gastric non-cardia adenocarcinoma (GNCC). How abdominal obesity, as commonly measured by waist circumference (WC), relates to these cancers remains largely unexplored. Using measured anthropometric data from 391,456 individuals from the European Prospective Investigation into Cancer and Nutrition (EPIC) study and 11 years of follow-up, we comprehensively assessed the association of anthropometric measures with risk of EAC, GCC and GNCC using multivariable proportional hazards regression. One hundred twenty-four incident EAC, 193 GCC and 224 GNCC were accrued. After mutual adjustment, BMI was unrelated to EAC, while WC showed a strong positive association (highest vs. lowest quintile HR = 1.19; 95% CI, 0.63-2.22 and HR = 3.76; 1.72-8.22, respectively). Hip circumference (HC) was inversely related to EAC after controlling for WC, while WC remained positively associated (HR = 0.35; 0.18-0.68, and HR=4.10; 1.94-8.63, respectively). BMI was not associated with GCC or GNCC. WC was related to higher risks of GCC after adjustment for BMI and more strongly after adjustment for HC (highest vs. lowest quintile HR = 1.91; 1.09-3.37, and HR = 2.23; 1.28-3.90, respectively). Our study demonstrates that abdominal, rather than general, obesity is an indisputable risk factor for EAC and also provides evidence for a protective effect of gluteofemoral (subcutaneous) adipose tissue in EAC. Our study further shows that general obesity is not a risk factor for GCC and GNCC, while the role of abdominal obesity in GCC needs further investigation.

Indexed as

AdenocarcinomaAdultAgedBody Mass IndexBody Weights and MeasuresEsophageal NeoplasmsEuropeFemaleFollow-Up StudiesHumansMaleMiddle AgedObesityObesity, AbdominalPopulation SurveillanceProspective Studiesabdominal obesitybody mass indexesophageal cancergastric cancergeneral obesitywaist circumference

Identifiers

PMID25598323
PMCPMC6292492
OpenAlexW1930606436

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.